0001209191-20-018979.txt : 20200313 0001209191-20-018979.hdr.sgml : 20200313 20200313172317 ACCESSION NUMBER: 0001209191-20-018979 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200312 FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cory David A CENTRAL INDEX KEY: 0001670137 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 20714017 MAIL ADDRESS: STREET 1: 350 CAMBRIDGE AVENUE, SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-12 0 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001670137 Cory David A C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 1 1 0 0 President and CEO Common Stock 2020-03-05 5 A 0 E 1500 7.31 A 69346 D Stock Option (Right to Buy) 5.60 2020-03-12 4 A 0 230000 0.00 A 2030-03-11 Common Stock 230000 230000 D These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The option vests in equal monthly installments over 48 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date. /s/ Sriram Ryali, Attorney-in-Fact 2020-03-13